M
Mats Eriksson
Researcher at RMIT University
Publications - 399
Citations - 11081
Mats Eriksson is an academic researcher from RMIT University. The author has contributed to research in topics: Medicine & Ordovician. The author has an hindex of 43, co-authored 361 publications receiving 9721 citations. Previous affiliations of Mats Eriksson include Swedish Radiation Safety Authority & Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
Effects of Torcetrapib in Patients at High Risk for Coronary Events
Philip J. Barter,Mark J. Caulfield,Mats Eriksson,Scott M. Grundy,John J.P. Kastelein,Michel Komajda,Jose Lopez-Sendon,Lori Mosca,Jean-Claude Tardif,David D. Waters,Charles L. Shear,James H. Revkin,Kevin A. Buhr,Marian R. Fisher,Alan R. Tall,Bryan Brewer +15 more
TL;DR: Although there was evidence of an off-target effect of torcetrapib, it cannot rule out adverse effects related to CETP inhibition, and the trial was terminated prematurely because of an increased risk of death and cardiac events.
Journal ArticleDOI
Effects of torcetrapib in patients at high risk for coronary events
Journal ArticleDOI
Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans.
TL;DR: Infusion of proapoA-I liposomes in humans promotes net cholesterol excretion from the body, implying a stimulation of reverse cholesterol transport, which may prove useful in the treatment of atherosclerosis.
Journal ArticleDOI
Analgesia in newborns given oral glucose
TL;DR: It is strongly suggested that 1 ml of a 30% glucose solution given orally alleviates mild pain significantly and can be used for this purpose in newborns.
Journal ArticleDOI
Influence of age on the metabolism of plasma low density lipoproteins in healthy males.
TL;DR: It is concluded that the increase in LDL which normally occurs with age is explained by a reduced capacity for its removal, and hypothesize that this is mediated via a reduced hepatic LDL receptor expression.